Nkarta, Inc. (NASDAQ:NKTX) Stock Has Average Price Target of $11.20 According to Brokerages

Shares of Nkarta, Inc. (NASDAQ:NKTX) have been assigned an average recommendation of “Moderate Buy” from the seven analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $11.20.

A number of research analysts recently issued reports on NKTX shares. Stifel Nicolaus dropped their price objective on shares of Nkarta from $11.00 to $10.00 and set a “buy” rating for the company in a report on Friday, August 14th. TD Cowen assumed coverage on shares of Nkarta in a report on Tuesday, June 23rd. They set a “buy” rating on the stock. HC Wainwright decreased their price target on shares of Nkarta to $14.00 and set a “buy” rating for the company in a research report on Tuesday, August 11th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Nkarta in a research note on Monday, September 21st. Finally, Wall Street Zen lowered shares of Nkarta from a “sell” rating to a “strong sell” rating in a report on Saturday, August 15th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of NKTX. BlackRock Inc. bought a new stake in shares of Nkarta in the 2nd quarter valued at about $17,830,000. Monaco Asset Management SAM bought a new position in shares of Nkarta during the second quarter worth about $6,717,000. AWM Investment Company Inc. bought a new position in shares of Nkarta during the second quarter worth about $2,564,000. Ieq Capital LLC bought a new position in shares of Nkarta during the second quarter worth about $501,000. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Nkarta by 74.4% in the first quarter. Dimensional Fund Advisors LP now owns 346,593 shares of the company’s stock worth $731,000 after acquiring an additional 147,894 shares during the period. 80.54% of the stock is owned by institutional investors.

Nkarta Price Performance

Shares of NKTX stock opened at $2.58 on Monday. Nkarta has a twelve month low of $1.70 and a twelve month high of $3.72. The stock’s fifty day simple moving average is $2.60 and its 200 day simple moving average is $2.69. The firm has a market capitalization of $184.78 million, a P/E ratio of -1.64 and a beta of 0.93.

Nkarta (NASDAQ:NKTX) last posted its earnings results on Monday, August 10th. The company reported ($0.54) EPS for the quarter, missing the consensus estimate of ($0.36) by ($0.18). As a group, equities research analysts expect that Nkarta will post -1.6 EPS for the current fiscal year.

About Nkarta

Nkarta, Inc (NASDAQ:NKTX) is a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies for cancer and autoimmune diseases. The company’s approach is designed to harness the innate immune activity of NK cells while using chimeric antigen receptors (CARs) to direct them toward specific disease-associated targets.

Nkarta’s development platform includes allogeneic, or donor-derived, CAR NK cell therapies intended to be manufactured for use across multiple patients.